Notice of Correction to the Funding Opportunity Description in PA-15-003 "Epidemiology of Drug Abuse (R01)"

Notice Number:

NOT-DA-14-053

Key Dates

Release Date:   October 22, 2014

Related Announcements

PA-15-003

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform the research community of an update to the funding opportunity description of PA-15-003 "Epidemiology of Drug Abuse (R01)".

Part 2. Section I. Funding Opportunity Description

Research Scope

Current language:

Methods & Measurement

Innovative statistical, genetic, or systems science methods and measurement, including research:

*Applying innovative methods or techniques from other disciplines that are novel to drug abuse research, such as utilization of systems science methodologies (e.g., agent based modeling, system dynamics modeling, network analysis) or geographic information systems (GIS);

*Improving the accuracy, efficiency, scope, timeliness, and analysis of drug use, abuse, and addiction epidemiologic data and research in areas described above, including projects that facilitate small sample estimation;

*Developing novel methodologies to improve the accuracy, efficiency, scope, timeliness, and analytic yield of epidemiologic data on drug abuse and inter-related health and social problems (e.g., HIV/AIDS, psychiatric comorbidity, poly-substance use, violence) particularly in hard to reach or underrepresented populations.

Revised language:

Methods & Measurement

Innovative statistical, genetic, or systems science methods and measurement, including research:

*Applying innovative methods or techniques from other disciplines that are novel to drug abuse research, such as utilization of systems science methodologies (e.g., agent based modeling, system dynamics modeling, network analysis) or geographic information systems (GIS);

*Improving the accuracy, efficiency, scope, timeliness, and analysis of drug use, abuse, and addiction epidemiologic data and research in areas described above, including projects that facilitate small sample estimation;

*Developing novel methodologies to improve the accuracy, efficiency, scope, timeliness, and analytic yield of epidemiologic data on drug abuse and inter-related health and social problems (e.g., HIV/AIDS, psychiatric comorbidity, poly-substance use, violence) particularly in hard to reach or underrepresented populations.

*Using psychometric methods to assess the test-retest reliability of the adult and youth baseline instruments used by the Population Assessment of Tobacco and Health (PATH) Study.  The PATH Study is a national longitudinal study of tobacco use and health that is following an estimated 46,000 U.S. household residents ages 12 and older who may or may not use tobacco.  Designed to examine patterns in tobacco product use and associated health conditions over time, the PATH Study will help to enhance the evidence base that informs FDA’s regulatory decisions in achieving the goals of the 2009 Family Smoking Prevention and Tobacco Control Act. 

All other aspects of the FOA remain the same

Inquiries

For more information and to discuss research ideas for assessing the test-retest reliability of the baseline instruments used by the PATH Study, investigators may direct inquiries to:

 
Kevin P. Conway, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-8755
Email: [email protected]